EyePoint (EYPT) Other Non-Current Liabilities (2011 - 2026)
EyePoint (EYPT) reported Other Non-Current Liabilities of $55000.0 for Q1 2026, down 68.93% on a YoY basis from $177000.0 in Q1 2025, and down 36.78% sequentially from $87000.0 in Q4 2025.
EyePoint (EYPT) Other Non-Current Liabilities (2011 - 2026) Analysis & Trends
EyePoint (EYPT) has 11 years of Other Non-Current Liabilities data on file, last reported at $55000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Liabilities fell 68.93% year-over-year to $55000.0; the trailing twelve-month figure through Mar 2026 stood at $55000.0 (down 68.93% YoY), and the FY2025 full-year result was $87000.0, down 57.56% from the prior year.
- Other Non-Current Liabilities slipped to $55000.0 in Q1 2026, from $87000.0 in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $658000.0 in Q1 2022 to a low of $100.0 in Q2 2024.
- A 5-year average of $298650.0 and a median of $191000.0 in 2024 frame the typical range for Other Non-Current Liabilities.
- Across the five-year window, Other Non-Current Liabilities plunged 83.33% in 2024 and jumped 147900.0% in 2025, its largest moves.
- Tracing EYPT's Other Non-Current Liabilities over 5 years: stood at $600000.0 in 2022, then changed by 0.0% to $600000.0 in 2023, then tumbled by 65.83% to $205000.0 in 2024, then plunged by 57.56% to $87000.0 in 2025, then sank by 36.78% to $55000.0 in 2026.
- Business Quant data shows EYPT's Other Non-Current Liabilities at $55000.0 in Q1 2026, $87000.0 in Q4 2025, and $118000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | EyePoint | 358.61 Mn | 136.07 Mn | 168,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 55,000.00 |
| Dec 31, 2025 | 87,000.00 |
| Sep 30, 2025 | 118,000.00 |
| Jun 30, 2025 | 148,000.00 |
| Mar 31, 2025 | 177,000.00 |
| Dec 31, 2024 | 205,000.00 |
| Sep 30, 2024 | 233,000.00 |
| Jun 30, 2024 | 100.00 |
| Mar 31, 2024 | 100,000.00 |
| Mar 31, 2023 | 600,000.00 |
| Dec 31, 2022 | 600,000.00 |
| Sep 30, 2022 | 600,000.00 |
| Jun 30, 2022 | 600,000.00 |
| Mar 31, 2022 | 658,000.00 |
| Dec 31, 2021 | 2.35 Mn |
| Sep 30, 2021 | 2.36 Mn |
| Jun 30, 2021 | 2.33 Mn |
| Mar 31, 2021 | 2.35 Mn |
| Dec 31, 2020 | 2.37 Mn |
| Sep 30, 2020 | 3.01 Mn |